XML 27 R19.htm IDEA: XBRL DOCUMENT
v3.26.1

Stockholders' Equity | 6 Months Ended
--- | ---
Mar. 31, 2026
Stockholders' Equity Note [Abstract] |
Stockholders' Equity | 10. Stockholders’ Equity The changes in stockholders’ equity for the prior year comparable period are as follows:
|  |  |  |  | Additional |  |  |  |  |  | Accumulated Other |  |  |  |  |
| Common Stock |  | Paid-in |  | Treasury Stock |  | Comprehensive |  | Retained |  |  |
| Shares |  | Amount |  | Capital |  | Shares |  | Amount |  | Loss |  | Earnings |  | Total |
Balance at September 30, 2024 |  | 36,707,840 |  | $ | 37 |  | $ | 275,771 |  |  | (6,015,496 | ) | $ | (93,854 | ) | $ | (9,427 | ) | $ | 10,033 |  | $ | 182,560 |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 5,810 |  |  | 5,810 |
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units |  | 138,838 |  |  | — |  |  | 114 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 114 |
Taxes paid associated with net settlement of stock compensation awards |  | (30,575 | ) |  | — |  |  | (883 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (883 | )
Forfeitures of restricted stock awards |  | (22,500 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Shares swapped to exercise stock options |  | — |  |  | — |  |  | 19 |  |  | (582 | ) |  | (19 | ) |  | — |  |  | — |  |  | — |
Stock compensation expense |  | — |  |  | — |  |  | 3,431 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 3,431 |
Foreign currency translation and other |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,871 | ) |  | — |  |  | (1,871 | )
Balance at December 31, 2024 |  | 36,793,603 |  | $ | 37 |  | $ | 278,452 |  |  | (6,016,078 | ) | $ | (93,873 | ) | $ | (11,298 | ) | $ | 15,843 |  | $ | 189,161 |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 7,051 |  |  | 7,051 |
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units |  | 522,121 |  |  | — |  |  | 78 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 78 |
Taxes paid associated with net settlement of stock compensation awards |  | (119,819 | ) |  | — |  |  | (3,957 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (3,957 | )
Acquisition consideration paid in common stock (Note 3) |  | 27,260 |  |  |  |  | 945 |  |  |  |  |  |  |  |  |  |  | 945 |
Shares swapped to exercise stock options |  | — |  |  | — |  |  | 28 |  |  | (815 | ) |  | (28 | ) |  | — |  |  | — |  |  | — |
Stock compensation expense |  | — |  |  | — |  |  | 2,578 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,578 |
Foreign currency translation |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 469 |  |  | — |  |  | 469 |
Balance at March 31, 2025 |  | 37,223,165 |  | $ | 37 |  | $ | 278,124 |  |  | (6,016,893 | ) | $ | (93,901 | ) | $ | (10,829 | ) | $ | 22,894 |  | $ | 196,325 |
Stock Compensation Incentive Plans The Company has several incentive plans under which stock options, restricted stock units (RSUs), restricted stock awards (RSAs), and cash-settled stock appreciation rights (SARs) have been issued, including the Third Amended and Restated 2006 Omnibus Long-Term Incentive Plan (as amended, the LTIP) and a plan and private placement issuances related to the Company’s acquisition of Machinio and Bid4Assets. During the six months ended March 31, 2026, the Company's shareholders approved an amendment to the LTIP to increase the authorized number of shares of common stock under the LTIP from 22,800,000 to 25,725,000. Vesting of RSUs and grants of RSAs count as 1.5x shares against the plan reserves. As of March 31, 2026, 3,325,286 shares of common stock remained available for use. Stock Compensation Expense The table below presents the components of share-based compensation expense (in thousands):
|  | Three Months Ended March 31, |  |  | Six Months Ended March 31, |
|  | 2026 |  |  | 2025 |  |  | 2026 |  |  | 2025 |
Equity-classified awards: |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  | $ | 677 |  |  | $ | 373 |  |  | $ | 1,726 |  |  | $ | 1,032 |
RSUs & RSAs |  |  | 3,673 |  |  |  | 2,205 |  |  |  | 8,798 |  |  |  | 4,978 |
Total Equity-classified awards |  | $ | 4,350 |  |  | $ | 2,578 |  |  | $ | 10,524 |  |  | $ | 6,010 |
The table below presents the components of share-based compensation expense by line-item within our Condensed Consolidated Statements of Operations (in thousands):
|  | Three Months Ended March 31, |  |  | Six Months Ended March 31, |
|  | 2026 |  |  | 2025 |  |  | 2026 |  |  | 2025 |
Stock compensation expense by function |  |  |  |  |  |  |  |  |  |  |  |
Technology and operations |  | $ | 682 |  |  | $ | 427 |  |  | $ | 1,623 |  |  | $ | 978 |
Sales and marketing |  |  | 1,427 |  |  |  | 853 |  |  |  | 3,333 |  |  |  | 1,875 |
General and administrative |  |  | 2,241 |  |  |  | 1,298 |  |  |  | 5,568 |  |  |  | 3,157 |
Total stock compensation expense: |  | $ | 4,350 |  |  | $ | 2,578 |  |  | $ | 10,524 |  |  | $ | 6,010 |
Stock Options and RSUs & RSAs The following table presents stock option and RSUs & RSAs grant activity:
﻿ |  | Six Months Ended March 31,2026 |
Stock Options granted: |  | ﻿ |
Options containing only service conditions: |  |  | 167,800 |
Weighted average exercise price |  | $ | 24.52 |
Weighted average grant date fair value |  | $ | 10.44 |
﻿ |  | ﻿ |
Options containing performance conditions: |  |  | 167,800 |
Weighted average exercise price |  | $ | 24.52 |
Weighted average grant date fair value |  | $ | 10.44 |
﻿ |  | ﻿ |
RSUs & RSAs granted: |  | ﻿ |
RSUs & RSAs containing only service conditions: |  |  | 356,650 |
Weighted average grant date fair value |  | $ | 27.21 |
﻿ |  | ﻿ |
RSUs & RSAs containing performance conditions: |  |  | 307,800 |
Weighted average grant date fair value |  | $ | 26.58 |
The stock options and RSUs & RSAs containing only service conditions will ve st over a one- to four-year service period. The stock options and RSUs & RSAs containing performance conditions will vest upon the achievement of specified financial targets of the Company, a segment, or a division of a segment and vests on the first day of each fiscal quarter over one- to four-year terms of the awards, starting with the first fiscal quarter after the first anniversary of the grant date. The range of assumptions used to determine the fair value of stock options using the Black-Scholes option-pricing model during the six months ended March 31, 2026, were as follows:
|  | Six Months Ended |
|  | March 31, 2026 |
Dividend yield |  |  | — |
Expected volatility |  | 45.93% - 53.51% |
Risk-free interest rate |  | 3.64% - 3.67% |
Expected term |  | 4.41 - 5.0 years |
Share Repurchase Program From time to time, we may be authorized to repurchase issued and outstanding shares of our common stock under a share repurchase program approved by our Board of Directors. Share repurchases may be made through open market purchases, privately negotiated transactions, or otherwise, at times and in such amounts as management deems appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements and other market conditions. The repurchase program may be discontinued or suspended at any time and will be funded using our available cash. As of September 30, 2025, the Company had $1.5 million of remaining authorization to repurchase shares through December 31, 2026. On November 17, 2025, the Company's Board of Directors authorized the repurchase of up to an additional $15.0 million of the Company's outstanding shares of common stock through December 31, 2027. The Company repurchased 1,430 shares for less than $0.1 million, and 56,676 shares for $1.5 million during the three and six months ended March 31, 2026, respectively. As of March 31, 2026, the Company had $15.0 million of remaining authorization to repurchase shares through December 31, 2027. Other Share Repurchases Separate from the share repurchase program, our stock incentive plans allow for participants to exercise stock options by surrendering shares of common stock equivalent in value to the exercise price due. Any shares surrendered to the Company in this manner are not available for future grant. During the six months ended March 31, 2026 and 2025, participants surrendered 3,519 and 1,397 shares of common stock in connection with the exercise of stock options, respectively.

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration